3 studies found for:    18356408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin;   Drug: Repaglinide;   Drug: Pioglitazone;   Drug: Gliclazide;   Drug: Glimepiride
2 Completed Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: EGT0001442;   Drug: Placebo
3 Completed
Has Results
Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: EGT0001474;   Drug: Placebo

Indicates status has not been verified in more than two years